Page 61 - Merck Sharp News Today

The most recent news from Nigeria and across the world is available at The News Chronicle. The News Chronicle provides the most recent headlines, commentary, and political news.

The antiviral for treating COVID-19 will soon arrive in the Czech Republic. Photo Credit: Freepik Prague, Aug 23 (CTK) - The Czech Health Ministry has signed a contract with US drug company Pfizer for a supply of the Paxlovid antiviral used for the treatment of COVID-19 until the end of this year

Adding nivolumab to neoadjuvant platinum-based chemotherapy can improve survival in patients with stage IIIA-B non-small cell lung cancer.

Looking at the state of unemployment across Africa, you find a tapestry weaved with stories of despair. The continent is brimming with young people eager to work, yet jobs are becoming less available. Chances are you likely know someone of ‘job-seeking’ age, hoping to find ‘anything’ to do because ‘things are tough’. But, unfortunately, hope […]

Many clinical trials supporting cancer drug approvals are ineligible for individual participant data sharing, a new study suggests.

Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA® in Recurrent/Metastatic Head and Neck Squamous Cell...

15.08.2022 - Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Phase 2 SIGNAL-HD Study Published in Nature Medicine Patient enrollment continues in ...

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today provided a corporate update and reported financial results for the second quarter ended June 30,...

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of a label expansion for the VENTANA MMR RxDx...

Adding nivolumab to neoadjuvant platinum-based chemotherapy can improve survival in patients with stage IIIA-B non-small cell lung cancer.